Spiritual Episodes of Drug-Induced State Help Cancer Patients Face...
Study findings published Thursday by Johns Hopkins and New York University School of Medicine researchers indicate psychotherapy fueled by a hallucinogenic called psilocybin, the active ingredient in...
View ArticleHeffter’s Plans for Future Research
With Phase 2 studies on cancer-related depression and anxiety now complete, Heffter is excited to investigate other conditions that might be successfully treated with psilocybin. Drawing on the...
View Article50th Anniversary Conference on Ethnopharmacologic Search for Psychoactive Drugs
Heffter scientist Dennis McKenna is heading the upcoming 50th-anniversary conference on the Ethnopharmacologic Search for Psychoactive Drugs. Website: https://espd50.com/ Facebook Event Page:...
View ArticleHeffter Marks A Milestone with 100th Scientific Publication
The 100th scientific publication with Heffter support has just been published, marking a milestone achievement for Heffter! The first one, in 1998, was about the safety of hallucinogens. Most of the...
View ArticleMicrodosing with LSD and its Research Potential
Recently there has been increased interest in microdosing LSD, that is, using doses of LSD that are not psychoactive (typically 10 micrograms). A standard recommendation is microdosing every three...
View ArticlePsilocybin-Induced Neuroplasticity in the Treatment of Major Depression
Yale University, Department of Psychiatry DOWNLOAD PDF Purpose: This study will investigate neurobiological and psychological effects of psilocybin-assisted therapy in people with major depressive...
View ArticleClik here to view.
Trends in The Top-Cited Articles on Classic Psychedelics
Since the founding of the Heffter Research Institute in 1993, Heffter-affiliated researchers account for 63% (17 of 27) of top-cited articles on classic psychedelics. The post Trends in The Top-Cited...
View ArticleFOOD WRITER MICHAEL POLLAN ON PSYCHEDELICS | MOTHER JONES
Legendary food writer Michael Pollan explains his interest in psychedelic plants in this podcast interview. Pollan discusses the re-emergence of psilocybin-assisted therapy research after long being...
View ArticleSurvey of difficult psychedelic experiences
The recent survey of difficult recreational psilocybin experiences by Heffter Board member and researcher Roland Griffiths, Ph.D. and his team at Johns Hopkins University draws two main conclusions...
View ArticleHeffter-Funded Studies Find Psilocybin Therapy Dramatically Reduces Anxiety...
Two randomized controlled trials published today in The Journal of Psychopharmacology report unprecedented findings on the use of psilocybin to dramatically reduce anxiety, depression and existential...
View Article
